Galderma Group AG
🇨🇭Switzerland
A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
Phase 4
Completed
- Conditions
- Injection Site Discomfort
- Interventions
- Device: Vibrating Beauty Bar
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 60
- Registration Number
- NCT06161246
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash
Phase 4
Completed
- Conditions
- Diaper Rash
- Interventions
- Drug: "Cetaphil Healing Ointment"
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 26
- Registration Number
- NCT06015217
- Locations
- 🇺🇸
Young Skin MD, Coral Springs, Florida, United States
Study to Evaluate the Safety and Effectiveness of GP0116
Not Applicable
Active, not recruiting
- Conditions
- Skin Manifestations
- Interventions
- Device: GP0116
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 186
- Registration Number
- NCT05987163
- Locations
- 🇺🇸
Galderma Investigational Site (Site#8074), Santa Monica, California, United States
🇺🇸Galderma Investigational Site (Site#8478), Vista, California, United States
🇺🇸Galderma Investigational Site (Site#8680), Westport, Connecticut, United States
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen
Not Applicable
Completed
- Conditions
- Photodamaged SkinVolume Deficiency of the Midface
- Interventions
- Combination Product: Sculptra and CeraVe Daily Moisturizing LotionCombination Product: Sculptra and Alastin Restorative Skin Complex
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 21
- Registration Number
- NCT05963204
- Locations
- 🇺🇸
Markowitz Medicals, New York, New York, United States
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
Not Applicable
Completed
- Conditions
- Chin AugmentationChin Retrusion
- Interventions
- Device: Restylane Lyft with LidocaineDevice: Juvederm Voluma XC
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 174
- Registration Number
- NCT05777759
- Locations
- 🇵🇷
Galderma Research Site, San Juan, Puerto Rico
🇺🇸United States, California, Manhattan Beach, California, United States
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Not Applicable
Completed
- Conditions
- Temporal Hollowing
- Interventions
- Device: Restylane Contour
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 225
- Registration Number
- NCT05691972
- Locations
- 🇺🇸
Galderma Research Site, Nashville, Tennessee, United States
Healing Ointment Usage Post-surgical Procedure
Phase 4
Completed
- Conditions
- Surgical Wound
- Interventions
- Drug: Cetaphil Healing Ointment
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 15
- Registration Number
- NCT05686928
- Locations
- 🇺🇸
Derm Texas, Dallas, Texas, United States
🇺🇸Legacy Dermatology, Frisco, Texas, United States
Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition
Not Applicable
Completed
- Conditions
- Jawline Definition
- Interventions
- Device: Restylane Lyft Lidocaine
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 140
- Registration Number
- NCT05622812
- Locations
- 🇨🇦
Galderma Research Site, Westmount, Quebec, Canada
Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers
Not Applicable
Completed
- Conditions
- Volume Deficiency of the Midface
- Interventions
- Device: Juvederm VolumaDevice: Restylane Contour
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 11
- Registration Number
- NCT05622851
- Locations
- 🇺🇸
The Aesthetic Clinique, Santa Rosa Beach, Florida, United States
Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
Not Applicable
Completed
- Conditions
- Gene Expression
- Interventions
- Device: SculptraDevice: Radiesse Plus
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 21
- Registration Number
- NCT05620043
- Locations
- 🇺🇸
Miami Dermatology & Laser Institute, Miami, Florida, United States